Статті в журналах з теми "Vaccinia virus"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Vaccinia virus".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Tartaglia, James, and Enzo Paoletti. "Recombinant vaccinia virus vaccines." Trends in Biotechnology 6, no. 2 (February 1988): 43–46. http://dx.doi.org/10.1016/0167-7799(88)90035-2.
Повний текст джерелаDoria-Rose, N. A., C. Ohlen, P. Polacino, C. C. Pierce, M. T. Hensel, L. Kuller, T. Mulvania, et al. "Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge." Journal of Virology 77, no. 21 (November 1, 2003): 11563–77. http://dx.doi.org/10.1128/jvi.77.21.11563-11577.2003.
Повний текст джерелаKUTINOVA, L. "Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them." Vaccine 13, no. 5 (1995): 487–93. http://dx.doi.org/10.1016/0264-410x(94)00019-j.
Повний текст джерелаPrecopio, Melissa L., Michael R. Betts, Janie Parrino, David A. Price, Emma Gostick, David R. Ambrozak, Tedi E. Asher, et al. "Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses." Journal of Experimental Medicine 204, no. 6 (May 29, 2007): 1405–16. http://dx.doi.org/10.1084/jem.20062363.
Повний текст джерелаTruong, Cao-Sang, and So Young Yoo. "Oncolytic Vaccinia Virus in Lung Cancer Vaccines." Vaccines 10, no. 2 (February 4, 2022): 240. http://dx.doi.org/10.3390/vaccines10020240.
Повний текст джерелаJacobs, Bertram L., Jeffrey O. Langland, Karen V. Kibler, Karen L. Denzler, Stacy D. White, Susan A. Holechek, Shukmei Wong, Trung Huynh, and Carole R. Baskin. "Vaccinia virus vaccines: Past, present and future." Antiviral Research 84, no. 1 (October 2009): 1–13. http://dx.doi.org/10.1016/j.antiviral.2009.06.006.
Повний текст джерелаSmith, Geoffrey L., Brendan J. Murphy, and Mansun Law. "Vaccinia Virus Motility." Annual Review of Microbiology 57, no. 1 (October 2003): 323–42. http://dx.doi.org/10.1146/annurev.micro.57.030502.091037.
Повний текст джерелаPerkus, M. E. "RECOMBINANT VACCINIA VIRUS." Pediatric Infectious Disease Journal 5, no. 2 (March 1986): 284. http://dx.doi.org/10.1097/00006454-198603000-00045.
Повний текст джерелаBroyles, Steven S. "Vaccinia virus transcription." Journal of General Virology 84, no. 9 (September 1, 2003): 2293–303. http://dx.doi.org/10.1099/vir.0.18942-0.
Повний текст джерелаStittelaar, Koert J., Geert van Amerongen, Ivanela Kondova, Thijs Kuiken, Rob F. van Lavieren, Frank H. M. Pistoor, Hubert G. M. Niesters, et al. "Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus." Journal of Virology 79, no. 12 (June 15, 2005): 7845–51. http://dx.doi.org/10.1128/jvi.79.12.7845-7851.2005.
Повний текст джерелаOber, B. T., P. Brühl, M. Schmidt, V. Wieser, W. Gritschenberger, S. Coulibaly, H. Savidis-Dacho, M. Gerencer, and F. G. Falkner. "Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara." Journal of Virology 76, no. 15 (August 1, 2002): 7713–23. http://dx.doi.org/10.1128/jvi.76.15.7713-7723.2002.
Повний текст джерелаKaufman, David R., Jaap Goudsmit, Lennart Holterman, Bonnie A. Ewald, Matthew Denholtz, Colleen Devoy, Ayush Giri, et al. "Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice." Journal of Virology 82, no. 14 (April 30, 2008): 6829–37. http://dx.doi.org/10.1128/jvi.00353-08.
Повний текст джерелаAhmed, Syed Faraz, Muhammad Saqib Sohail, Ahmed Abdul Quadeer, and Matthew R. McKay. "Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus." Viruses 14, no. 9 (September 3, 2022): 1960. http://dx.doi.org/10.3390/v14091960.
Повний текст джерелаHruby, D. E. "Vaccinia virus vectors: new strategies for producing recombinant vaccines." Clinical Microbiology Reviews 3, no. 2 (April 1990): 153–70. http://dx.doi.org/10.1128/cmr.3.2.153.
Повний текст джерелаMaksyutov, Rinat A., Elena V. Gavrilova, Galina V. Kochneva, and Sergei N. Shchelkunov. "Immunogenicity and Protective Efficacy of a Polyvalent DNA Vaccine against Human Orthopoxvirus Infections Based on Smallpox Virus Genes." Journal of Vaccines 2013 (August 21, 2013): 1–8. http://dx.doi.org/10.1155/2013/618324.
Повний текст джерелаSebastian, Sarah, and Sarah C. Gilbert. "Recombinant modified vaccinia virus Ankara-based malaria vaccines." Expert Review of Vaccines 15, no. 1 (October 29, 2015): 91–103. http://dx.doi.org/10.1586/14760584.2016.1106319.
Повний текст джерелаGilbert, Sarah C. "Clinical development of Modified Vaccinia virus Ankara vaccines." Vaccine 31, no. 39 (September 2013): 4241–46. http://dx.doi.org/10.1016/j.vaccine.2013.03.020.
Повний текст джерелаPaoletti, Enzo, Marion E. Perkus, and Antonia Piccini. "Live recombinant vaccines using genetically engineered vaccinia virus." Antiviral Research 5 (January 1985): 301–7. http://dx.doi.org/10.1016/s0166-3542(85)80042-5.
Повний текст джерелаKaplan, C. "Vaccinia virus: a suitable vehicle for recombinant vaccines?" Archives of Virology 106, no. 1-2 (March 1989): 127–39. http://dx.doi.org/10.1007/bf01311044.
Повний текст джерелаHughes, Christine M., Frances K. Newman, Whitni B. Davidson, Victoria A. Olson, Scott K. Smith, Robert C. Holman, Lihan Yan, et al. "Analysis of Variola and Vaccinia Virus Neutralization Assays for Smallpox Vaccines." Clinical and Vaccine Immunology 19, no. 7 (May 16, 2012): 1116–18. http://dx.doi.org/10.1128/cvi.00056-12.
Повний текст джерелаWatanabe, Shumpei, Tomoki Yoshikawa, Yoshihiro Kaku, Takeshi Kurosu, Shuetsu Fukushi, Satoko Sugimoto, Yuki Nishisaka, et al. "Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8." PLOS Neglected Tropical Diseases 17, no. 12 (December 15, 2023): e0011851. http://dx.doi.org/10.1371/journal.pntd.0011851.
Повний текст джерелаVerardi, Paulo H., Allison Titong, and Caitlin J. Hagen. "A vaccinia virus renaissance." Human Vaccines & Immunotherapeutics 8, no. 7 (July 2012): 961–70. http://dx.doi.org/10.4161/hv.21080.
Повний текст джерелаZaslavsky, V. "Uncoating of vaccinia virus." Journal of Virology 55, no. 2 (1985): 352–56. http://dx.doi.org/10.1128/jvi.55.2.352-356.1985.
Повний текст джерелаMOSS, BERNARD, and CHARLES FLEXNER. "Vaccinia Virus Expression Vectors." Annals of the New York Academy of Sciences 569, no. 1 Biomedical Sc (December 1989): 86–103. http://dx.doi.org/10.1111/j.1749-6632.1989.tb27360.x.
Повний текст джерелаSmith, Geoffrey L., Julian A. Symons, Anu Khanna, Alain Vanderplasschen, and Antonio Alcami. "Vaccinia virus immune evasion." Immunological Reviews 159, no. 1 (October 1997): 137–54. http://dx.doi.org/10.1111/j.1600-065x.1997.tb01012.x.
Повний текст джерелаYakubitskiy, S. N., I. V. Kolosova, R. A. Maksyutov, and S. N. Shchelkunov. "Attenuation of Vaccinia Virus." Acta Naturae 7, no. 4 (December 15, 2015): 113–21. http://dx.doi.org/10.32607/20758251-2015-7-4-113-121.
Повний текст джерелаSmith, Geoffrey L. "Vaccinia virus immune evasion." Immunology Letters 65, no. 1-2 (January 1999): 55–62. http://dx.doi.org/10.1016/s0165-2478(98)00125-4.
Повний текст джерелаMackett, M., and G. L. Smith. "Vaccinia Virus Expression Vectors." Journal of General Virology 67, no. 10 (October 1, 1986): 2067–82. http://dx.doi.org/10.1099/0022-1317-67-10-2067.
Повний текст джерелаMoss, B., and C. Flexner. "Vaccinia Virus Expression Vectors." Annual Review of Immunology 5, no. 1 (April 1987): 305–24. http://dx.doi.org/10.1146/annurev.iy.05.040187.001513.
Повний текст джерелаBielinska, Anna U., Alexander A. Chepurnov, Jeffrey J. Landers, Katarzyna W. Janczak, Tatiana S. Chepurnova, Gary D. Luker, and James R. Baker. "A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine." Clinical and Vaccine Immunology 15, no. 2 (December 5, 2007): 348–58. http://dx.doi.org/10.1128/cvi.00440-07.
Повний текст джерелаYe, Chunting, Jang Gi Choi, Sojan Abraham, Premlata Shankar, and Manjunath Swamy. "Targeting DNA vaccines to dendritic cells using a small peptide to enhance immune response (VAC4P.1110)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 72.15. http://dx.doi.org/10.4049/jimmunol.194.supp.72.15.
Повний текст джерелаWhitehouse, Erin R., Agam Rao, Yon Yu, Patricia Yu, Margaret Griffin, Susan E. Gorman, Kristen A. Angel, et al. "1207. Vaccinia Virus Infection Acquired from an Occupational Needlestick—San Diego, California, 2019." Open Forum Infectious Diseases 6, Supplement_2 (October 2019): S434. http://dx.doi.org/10.1093/ofid/ofz360.1070.
Повний текст джерелаHolzer, G. W., G. Remp, G. Antoine, M. Pfleiderer, O. M. Enzersberger, W. Emsenhuber, T. Hämmerle, et al. "Highly Efficient Induction of Protective Immunity by a Vaccinia Virus Vector Defective in Late Gene Expression." Journal of Virology 73, no. 6 (June 1, 1999): 4536–42. http://dx.doi.org/10.1128/jvi.73.6.4536-4542.1999.
Повний текст джерелаMeseda, Clement A., Anne E. Mayer, Arunima Kumar, Alonzo D. Garcia, Joseph Campbell, Paul Listrani, Jody Manischewitz, et al. "Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model." Clinical and Vaccine Immunology 16, no. 9 (July 15, 2009): 1261–71. http://dx.doi.org/10.1128/cvi.00040-09.
Повний текст джерелаAdamo, Joan E., Clement A. Meseda, Jerry P. Weir, and Michael J. Merchlinsky. "Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein." Journal of General Virology 90, no. 11 (November 1, 2009): 2604–8. http://dx.doi.org/10.1099/vir.0.008474-0.
Повний текст джерелаHruby, D. E. "Vaccinia virus vectors: new strategies for producing recombinant vaccines." Clinical Microbiology Reviews 3, no. 2 (1990): 153–70. http://dx.doi.org/10.1128/cmr.3.2.153-170.1990.
Повний текст джерелаTack, Danielle M., Kevin L. Karem, Jay R. Montgomery, Limone Collins, Marthe G. Bryant-Genevier, Rosemary Tiernan, Maria Cano, et al. "Unintentional transfer of vaccinia virus associated with smallpox vaccines." Human Vaccines & Immunotherapeutics 9, no. 7 (April 9, 2013): 1489–96. http://dx.doi.org/10.4161/hv.24319.
Повний текст джерелаPrideaux, Christopher T., Sharad Kumar, and David B. Boyle. "Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants." Virus Research 16, no. 1 (April 1990): 43–57. http://dx.doi.org/10.1016/0168-1702(90)90042-a.
Повний текст джерелаChung, Che-Sheng, Chein-Hung Chen, Ming-Yi Ho, Cheng-Yen Huang, Chung-Lin Liao, and Wen Chang. "Vaccinia Virus Proteome: Identification of Proteins in Vaccinia Virus Intracellular Mature Virion Particles." Journal of Virology 80, no. 5 (March 1, 2006): 2127–40. http://dx.doi.org/10.1128/jvi.80.5.2127-2140.2006.
Повний текст джерелаLeite, Juliana A., Betânia P. Drumond, Giliane S. Trindade, Zélia I. P. Lobato, Flávio G. da Fonseca, João R. dos Santos, Marieta C. Madureira, et al. "Passatempo Virus, a Vaccinia Virus Strain, Brazil." Emerging Infectious Diseases 11, no. 12 (December 2005): 1935–41. http://dx.doi.org/10.3201/eid1112.050773.
Повний текст джерелаRamírez, Juan C., M. Magdalena Gherardi, Dolores Rodríguez, and Mariano Esteban. "Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector." Journal of Virology 74, no. 16 (August 15, 2000): 7651–55. http://dx.doi.org/10.1128/jvi.74.16.7651-7655.2000.
Повний текст джерелаBenning, Nicola, and Daniel E. Hassett. "Vaccinia Virus Infection during Murine Pregnancy: a New Pathogenesis Model for Vaccinia Fetalis." Journal of Virology 78, no. 6 (March 15, 2004): 3133–39. http://dx.doi.org/10.1128/jvi.78.6.3133-3139.2004.
Повний текст джерелаKlote, Mary M., George V. Ludwig, Melanie P. Ulrich, Lisa A. Black, Dallas C. Hack, Renata J. M. Engler, and Bryan L. Martin. "Absence of oropharyngeal vaccinia virus after vaccinia (smallpox) vaccination." Annals of Allergy, Asthma & Immunology 94, no. 6 (June 2005): 682–85. http://dx.doi.org/10.1016/s1081-1206(10)61328-2.
Повний текст джерелаO'Neil, B. H., Y. Kawakami, N. P. Restifo, J. R. Bennink, J. W. Yewdell, and S. A. Rosenberg. "Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA." Journal of Immunology 151, no. 3 (August 1, 1993): 1410–18. http://dx.doi.org/10.4049/jimmunol.151.3.1410.
Повний текст джерелаChung, Che-Sheng, Jye-Chian Hsiao, Yuan-Shau Chang, and Wen Chang. "A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate." Journal of Virology 72, no. 2 (February 1, 1998): 1577–85. http://dx.doi.org/10.1128/jvi.72.2.1577-1585.1998.
Повний текст джерелаSutter, Gerd, and Caroline Staib. "Vaccinia Vectors as Candidate Vaccines: The Development of Modified Vaccinia Virus Ankara for Antigen Delivery." Current Drug Target -Infectious Disorders 3, no. 3 (September 1, 2003): 263–71. http://dx.doi.org/10.2174/1568005033481123.
Повний текст джерелаHuang, Cheng-Yen, Tsai-Yi Lu, Chi-Horng Bair, Yuan-Shau Chang, Jeng-Kuan Jwo, and Wen Chang. "A Novel Cellular Protein, VPEF, Facilitates Vaccinia Virus Penetration into HeLa Cells through Fluid Phase Endocytosis." Journal of Virology 82, no. 16 (June 11, 2008): 7988–99. http://dx.doi.org/10.1128/jvi.00894-08.
Повний текст джерелаMoses, Phyllis B. "Vaccinia Virus: Reinventing the Wheel." BioScience 36, no. 3 (March 1986): 148–50. http://dx.doi.org/10.2307/1310299.
Повний текст джерелаAssis, Felipe Lopes, Iara Apolinario Borges, Paulo César Peregrino Ferreira, Cláudio Antônio Bonjardim, Giliane de Souza Trindade, Zélia Inês Portela Lobato, Maria Isabel Maldonado Guedes, Vaz Mesquita, Erna Geessien Kroon, and Jônatas Santos Abrahão. "Group 2 Vaccinia Virus, Brazil." Emerging Infectious Diseases 18, no. 12 (December 2012): 2035–38. http://dx.doi.org/10.3201/eid1812.120145.
Повний текст джерелаMoss, B. "Regulation of Vaccinia Virus Transcription." Annual Review of Biochemistry 59, no. 1 (June 1990): 661–88. http://dx.doi.org/10.1146/annurev.bi.59.070190.003305.
Повний текст джерела